Order Article Reprints

Prelaj A, Boeri M, Robuschi A, Ferrara R, Proto C, Lo Russo G, Galli G, De Toma A, Brambilla M, Occhipinti M, et al. Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy. Cancers. 2022; 14(2):435. https://doi.org/10.3390/cancers14020435

Prelaj, Arsela, Mattia Boeri, Alessandro Robuschi, Roberto Ferrara, Claudia Proto, Giuseppe Lo Russo, Giulia Galli, Alessandro De Toma, Marta Brambilla, Mario Occhipinti, and et al. 2022. "Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy" Cancers 14, no. 2: 435. https://doi.org/10.3390/cancers14020435

Prelaj, A., Boeri, M., Robuschi, A., Ferrara, R., Proto, C., Lo Russo, G., Galli, G., De Toma, A., Brambilla, M., Occhipinti, M., Manglaviti, S., Beninato, T., Bottiglieri, A., Massa, G., Zattarin, E., Gallucci, R., Galli, E. G., Ganzinelli, M., Sozzi, G., ... Trovo', F. (2022). Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy. Cancers, 14(2), 435. https://doi.org/10.3390/cancers14020435